Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Post by SamV21on Mar 11, 2023 5:13pm
248 Views
Post# 35332884

Keep dreaming and wasting shareholders money Phase 1

Keep dreaming and wasting shareholders money Phase 1 AUSTIN, TexasApril 26, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct Biologics is the first and only EV company to receive FDA Phase 3 approval for an Investigational New Drug (IND) indication to date. 

Once again Guy is in lala land ,  he will never catch up to real world science , all these dreams take time and money which Tetra has neither .Stock will never trade again if Guy has his way , some private company will buy Tetra and shareholders will be left with nothing, its all about Guy and HIS science that he spent our money on over the years , go back and read the news releases saying revenue next year , he promised to be selling Reduvo by the end of 2021 . This phase 1 study has not even started yet , product is worth nothing till Phase 3 and that will be 10 years away. Wake up , dreamer .Direct Biologics is only one companies in the Ards race, there are many others  in Phase 3 development with deep pockets to fund their research and solid medical Dr.s behind them .Guy is a general contractor putting deals together to keep his over paid wage going , when the company is moved to a private Inc. company shareholders will be left with nothing and Guy will continue with the renamed privately held Inc. perhaps his own 93154466 Quebec Inc. I really hope I am wrong but the pattern of lies, performance and truthful  communication and lack there of  by Guy and Tetra screams , here we go again more dead end money . I have called the re/max realtor in Ontario that has the building for lease where Tetra's office should be in Ontario last year and was told the whole building was empty and for lease. So Tetra mail is most likely just being forwarded to his residence.
160,000,000 deficit 
460,000,000 outstanding shares dilutted to death , sold off piece by piece 
Upcoming promised payments to Panag Pharma 1,200.000 every year till 2029 if payments are not made 15,000,000 becomes due ( read page 31 in your magagement's discussion and Analysis from August 2022 ) page 32 another 13,800,999 due , 1,000,000 to Lumiea Health Innovations Inc , I think Guy had his private company connected to that deal,  Debenture another 3,000,000 
I haven't even touched on the over 1,500,000 annual interest paid out. 
Have we spent your 4,500,000 yet ? 
Broke is broke , Guy doesn't function in reality for Tetra and its shareholders , never has and  never will, that is why we are halted , shareholders didn't cause the halt Guy the CEO did.
<< Previous
Bullboard Posts
Next >>